• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies.DNA疫苗诱导的CD8+ T淋巴细胞表位免疫显性等级的调控
J Virol. 2006 Dec;80(24):11991-7. doi: 10.1128/JVI.01348-06. Epub 2006 Sep 27.
2
A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.一种具有复制能力的腺病毒5型宿主范围突变体-猴免疫缺陷病毒(SIV)重组初免/亚单位蛋白加强疫苗方案可诱导Mamu-A*01恒河猴对显性和隐性表位产生广泛、持久的SIV特异性细胞免疫。
J Immunol. 2003 Apr 15;170(8):4281-9. doi: 10.4049/jimmunol.170.8.4281.
3
Silencing an immunodominant epitope of hepatitis B surface antigen reveals an alternative repertoire of CD8 T cell epitopes of this viral antigen.沉默乙肝表面抗原的免疫优势表位揭示了该病毒抗原的 CD8 T 细胞表位的另一个替代库。
Vaccine. 2009 Dec 10;28(1):114-9. doi: 10.1016/j.vaccine.2009.09.096. Epub 2009 Oct 8.
4
Recombinant canarypox vaccine-elicited CTL specific for dominant and subdominant simian immunodeficiency virus epitopes in rhesus monkeys.重组金丝雀痘病毒疫苗在恒河猴体内引发针对猿猴免疫缺陷病毒显性和隐性表位的细胞毒性T淋巴细胞。
J Immunol. 2002 Feb 15;168(4):1847-53. doi: 10.4049/jimmunol.168.4.1847.
5
Immunodomination in the evolution of dominant epitope-specific CD8+ T lymphocyte responses in simian immunodeficiency virus-infected rhesus monkeys.猕猴免疫缺陷病毒感染的恒河猴中优势表位特异性CD8 + T淋巴细胞反应演变中的免疫显性
J Immunol. 2006 Jan 1;176(1):319-28. doi: 10.4049/jimmunol.176.1.319.
6
DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV.DNA初免-加强疫苗方案可增强针对猿猴免疫缺陷病毒和HIV的次要Gag表位的细胞免疫反应的广度、强度和细胞毒性。
J Immunol. 2016 Nov 15;197(10):3999-4013. doi: 10.4049/jimmunol.1600697. Epub 2016 Oct 12.
7
Therapeutic conserved elements (CE) DNA vaccine induces strong T-cell responses against highly conserved viral sequences during simian-human immunodeficiency virus infection.治疗性保守元件 (CE) DNA 疫苗可在感染猴免疫缺陷病毒期间诱导针对高度保守病毒序列的强烈 T 细胞反应。
Hum Vaccin Immunother. 2018 Jul 3;14(7):1820-1831. doi: 10.1080/21645515.2018.1448328. Epub 2018 Apr 12.
8
Contribution of T-cell receptor repertoire breadth to the dominance of epitope-specific CD8+ T-lymphocyte responses.T细胞受体库广度对表位特异性CD8 + T淋巴细胞反应优势的贡献。
J Virol. 2006 Dec;80(24):12032-40. doi: 10.1128/JVI.01479-06. Epub 2006 Oct 11.
9
Immunodominance in virus-induced CD8(+) T-cell responses is dramatically modified by DNA immunization and is regulated by gamma interferon.病毒诱导的CD8(+) T细胞反应中的免疫显性通过DNA免疫得到显著改变,并受γ干扰素调控。
J Virol. 2002 May;76(9):4251-9. doi: 10.1128/jvi.76.9.4251-4259.2002.
10
Dominant CD8+ T-lymphocyte responses suppress expansion of vaccine-elicited subdominant T lymphocytes in rhesus monkeys challenged with pathogenic simian-human immunodeficiency virus.在受到致病性猿猴-人类免疫缺陷病毒攻击的恒河猴中,占主导地位的CD8 + T淋巴细胞反应会抑制疫苗引发的次要T淋巴细胞的扩增。
J Virol. 2009 Oct;83(19):10028-35. doi: 10.1128/JVI.01015-09. Epub 2009 Jul 29.

引用本文的文献

1
Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern Africa.在HIV-CORE 006中,由ChAdOx1和MVA载体的HIVconsvX保守嵌合候选T细胞疫苗在非洲东部和南部未感染HIV-1的健康成年人中的安全性和广泛免疫原性:一项双盲、随机、安慰剂对照的1期试验
Lancet Microbe. 2025 Jun;6(6):101041. doi: 10.1016/j.lanmic.2024.101041. Epub 2025 May 16.
2
Early spatiotemporal evolution of the immune response elicited by adenovirus serotype 26 vector vaccination in mice.26型腺病毒载体疫苗接种小鼠后引发的免疫反应的早期时空演变
J Virol. 2025 May 20;99(5):e0024725. doi: 10.1128/jvi.00247-25. Epub 2025 Mar 31.
3
A candidate subunit vaccine induces protective immunity against Mycobacterium avium subspecies paratuberculosis in mice.一种候选亚单位疫苗可诱导小鼠对副结核分枝杆菌鸟亚种产生保护性免疫。
NPJ Vaccines. 2023 May 20;8(1):72. doi: 10.1038/s41541-023-00675-1.
4
Rapid Cloning of Novel Rhesus Adenoviral Vaccine Vectors.新型恒河猴腺病毒疫苗载体的快速克隆
J Virol. 2018 Feb 26;92(6). doi: 10.1128/JVI.01924-17. Print 2018 Mar 15.
5
Conserved HIV-1 Gag p24 Epitopes Elicit Cellular Immune Responses That Impact Disease Outcome.保守的HIV-1 Gag p24表位引发影响疾病转归的细胞免疫反应。
AIDS Res Hum Retroviruses. 2017 Aug;33(8):832-842. doi: 10.1089/AID.2016.0168. Epub 2017 Aug 3.
6
The Five Immune Forces Impacting DNA-Based Cancer Immunotherapeutic Strategy.影响基于DNA的癌症免疫治疗策略的五种免疫力量。
Int J Mol Sci. 2017 Mar 17;18(3):650. doi: 10.3390/ijms18030650.
7
Adenovirus serotype 5 vaccine vectors trigger IL-27-dependent inhibitory CD4 T cell responses that impair CD8 T cell function.5型腺病毒疫苗载体引发依赖白细胞介素-27的抑制性CD4 T细胞反应,损害CD8 T细胞功能。
Sci Immunol. 2016 Nov;1(5). doi: 10.1126/sciimmunol.aaf7643. Epub 2016 Nov 4.
8
Increased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope Recognition.保守镶嵌疫苗的价数增加可增强表位识别的广度和深度。
Mol Ther. 2016 Feb;24(2):375-384. doi: 10.1038/mt.2015.210. Epub 2015 Nov 19.
9
Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization.通过载体化减弱具有复制能力的26型腺病毒疫苗
Clin Vaccine Immunol. 2015 Nov;22(11):1166-75. doi: 10.1128/CVI.00510-15. Epub 2015 Sep 16.
10
HIV DNA Vaccine: Stepwise Improvements Make a Difference.HIV DNA疫苗:逐步改进产生显著效果。
Vaccines (Basel). 2014 May 14;2(2):354-79. doi: 10.3390/vaccines2020354.

本文引用的文献

1
Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes.通过靶向次显性表位的细胞毒性T淋巴细胞控制人类免疫缺陷病毒复制
Nat Immunol. 2006 Feb;7(2):173-8. doi: 10.1038/ni1281. Epub 2005 Dec 20.
2
Immunodomination in the evolution of dominant epitope-specific CD8+ T lymphocyte responses in simian immunodeficiency virus-infected rhesus monkeys.猕猴免疫缺陷病毒感染的恒河猴中优势表位特异性CD8 + T淋巴细胞反应演变中的免疫显性
J Immunol. 2006 Jan 1;176(1):319-28. doi: 10.4049/jimmunol.176.1.319.
3
Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys.基于重组纤维嵌合35型腺病毒载体疫苗在小鼠和恒河猴中的免疫原性。
J Virol. 2005 Nov;79(22):14161-8. doi: 10.1128/JVI.79.22.14161-14168.2005.
4
Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunity.在存在抗Ad5免疫力的情况下,涉及重组11型腺病毒(Ad11)和Ad35疫苗载体的异源初免-加强免疫方案的免疫原性。
J Virol. 2005 Aug;79(15):9694-701. doi: 10.1128/JVI.79.15.9694-9701.2005.
5
Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines.体内树突状细胞的募集与扩增可增强质粒DNA疫苗的免疫原性。
J Clin Invest. 2004 Nov;114(9):1334-42. doi: 10.1172/JCI22608.
6
Reversal in the immunodominance hierarchy in secondary CD8+ T cell responses to influenza A virus: roles for cross-presentation and lysis-independent immunodomination.甲型流感病毒特异性CD8+ T细胞二次免疫应答中免疫显性等级的逆转:交叉提呈及非裂解性免疫显性的作用
J Immunol. 2004 Oct 15;173(8):5021-7. doi: 10.4049/jimmunol.173.8.5021.
7
Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity.在预先存在抗Ad5免疫力的情况下重组35型腺病毒疫苗的免疫原性。
J Immunol. 2004 May 15;172(10):6290-7. doi: 10.4049/jimmunol.172.10.6290.
8
Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression.抗病毒细胞毒性T细胞反应的免疫显性由病毒蛋白表达的动力学所塑造。
J Immunol. 2003 Nov 15;171(10):5415-22. doi: 10.4049/jimmunol.171.10.5415.
9
Changing immunodominance patterns in antiviral CD8 T-cell responses after loss of epitope presentation or chronic antigenic stimulation.表位呈递丧失或慢性抗原刺激后抗病毒CD8 T细胞反应中免疫显性模式的改变。
Virology. 2003 Oct 10;315(1):93-102. doi: 10.1016/j.virol.2003.07.001.
10
Magnitude and diversity of cytotoxic-T-lymphocyte responses elicited by multiepitope DNA vaccination in rhesus monkeys.恒河猴中多表位DNA疫苗引发的细胞毒性T淋巴细胞反应的强度和多样性。
J Virol. 2003 Sep;77(18):10113-8. doi: 10.1128/jvi.77.18.10113-10118.2003.

DNA疫苗诱导的CD8+ T淋巴细胞表位免疫显性等级的调控

Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies.

作者信息

Liu Jinyan, Ewald Bonnie A, Lynch Diana M, Nanda Anjali, Sumida Shawn M, Barouch Dan H

机构信息

Research East Room 213, Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA.

出版信息

J Virol. 2006 Dec;80(24):11991-7. doi: 10.1128/JVI.01348-06. Epub 2006 Sep 27.

DOI:10.1128/JVI.01348-06
PMID:17005652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1676306/
Abstract

Generating broad cellular immune responses against a diversity of viral epitopes is a major goal of current vaccine strategies for human immunodeficiency virus type 1 (HIV-1) and other pathogens. Virus-specific CD8(+) T-lymphocyte responses, however, are often highly focused on a very limited number of immunodominant epitopes. For an HIV-1 vaccine, the breadth of CD8(+) T-lymphocyte responses may prove to be critical as a result of the need to cover a wide diversity of viral isolates in the population and to limit viral escape from dominant epitope-specific T lymphocytes. Here we show that epitope modification strategies can alter CD8(+) T-lymphocyte epitope immunodominance hierarchies elicited by a DNA vaccine in mice. Mice immunized with a DNA vaccine expressing simian immunodeficiency virus Gag lacking the dominant D(b)-restricted AL11 epitope generated a marked and durable augmentation of responses specific for the subdominant D(b)-restricted KV9 epitope. Moreover, anatomic separation strategies and heterologous prime-boost regimens generated codominant responses against both epitopes. These data demonstrate that dominant epitopes can dramatically suppress the immunogenicity of subdominant epitopes in the context of gene-based vaccines and that epitope modification strategies can be utilized to enhance responses to subdominant epitopes.

摘要

产生针对多种病毒表位的广泛细胞免疫反应是目前针对人类免疫缺陷病毒1型(HIV-1)和其他病原体的疫苗策略的主要目标。然而,病毒特异性CD8(+) T淋巴细胞反应通常高度集中于极少数免疫显性表位。对于HIV-1疫苗而言,由于需要覆盖人群中广泛多样的病毒分离株并限制病毒从显性表位特异性T淋巴细胞中逃逸,CD8(+) T淋巴细胞反应的广度可能至关重要。在此我们表明,表位修饰策略可改变DNA疫苗在小鼠中引发的CD8(+) T淋巴细胞表位免疫显性等级。用表达缺乏显性D(b)限制性AL11表位的猿猴免疫缺陷病毒Gag的DNA疫苗免疫的小鼠,对次显性D(b)限制性KV9表位产生的反应显著且持久增强。此外,解剖学分离策略和异源初免-加强方案产生了针对这两种表位的共显性反应。这些数据表明,在基于基因的疫苗背景下,显性表位可显著抑制次显性表位的免疫原性,且表位修饰策略可用于增强对次显性表位的反应。